Control of stromal keratitis by inhibition of neovascularization

American Journal of Pathology

Volumn 159, Issue 3, 2001, Pages 1021-1029

  Zheng, Mei ^a   Schwarz, Margaret A ^b   Lee, Sujin ^a   Kumaraguru, Uday ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KERATITIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TOPICAL TREATMENT; VASCULAR ENDOTHELIUM;

EID: 0034856148     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61777-4     Document Type: Article

References (36)

1. Immunity causing blindness: Five different paths to herpes stromal keratitis
2. Herpes simplex virus-induced stromal keratitis: Role of T lymphocyte subsets in immunopathology
3. Immunopathogenesis of herpetic ocular disease
4. Virus induced immunoinflammatory lesions in the absence of viral antigen recognition
5. Molecular mimicry by herpes simplex virus type 1: Autoimmune disease after viral infection
6. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: No evidence for autoreactive T cells
7. Herpes simplex replication induces expression of chemokines and proinflammatory cytokines in eye implications in herpetic stromal keratitis
8. On the essential involvement of neutrophils in the immunopathological disease herpetic stromal keratitis
9. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea
10. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells
11. Endothelial monocyte activating polypeptide II induces apoptosis and may inhibit tumor endothelial cell angiogenesis
12. EMAP II Inhibits lung neovascularization and airway epithelial morphogenesis
13. Tumor necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte-activating polypeptide II (EMAP-II)
14. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAP II)
15. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms
16. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II
17. Topical modulation of interleukin-1 activity in corneal neovascularization
18. A model of angiogenesis in the mouse cornea
19. Culture of endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
20. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
21. Role of T lymphocytes in the pathogenesis of herpetic stromal keratitis
22. High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis
23. Vascular endothelial growth factor: Molecular and biological aspects
24. Anti-angiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma
25. Herpes simplex virus disease: Anterior segment of the eye
26. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice
27. EMAP II: A modulator of neovascularization in the developing lung
28. Temporo-spatial distribution of endothelialmonocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo
29. Vascular-specific growth factor and blood vessel formation
30. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis
31. Suppression of tumor growth though disruption of hypoxia-inducible transcription
32. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a v oncogene and angiogenesis activator
33. Kaposi's sarcoma. Coupling herpesvirus to angiogenesis
34. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signaling through VEGF-2 (KDR) but not VEGF (flt-1) receptor tyrosine kinase
35. Herpes simplex virus and the immune response: A balance of power
36. Herpes simplex viruses and their replication